Alzheimer's disease: Aβ, tau and synaptic dysfunction

Trends in Molecular Medicine

Volumn 11, Issue 4, 2005, Pages 170-176

  LaFerla, Frank M ^a   Oddo, Salvatore ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; CELL LOSS; DEGENERATIVE DISEASE; HUMAN; IN VIVO STUDY; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PLASTICITY; PROTEIN AGGREGATION; REVIEW; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE;

EID: 17044439021     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2005.02.009     Document Type: Review

References (58)

1. R. Brookmeyer Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset Am. J. Public Health 88 1998 1337 1342
2. J.S. Walsh Survival of outpatients with Alzheimer-type dementia Ann. Intern. Med. 113 1990 429 434
3. M.C. Chartier-Harlin Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene Nature 353 1991 844 846
4. A. Goate Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 349 1991 704 706
5. R. Sherrington Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Nature 375 1995 754 760
6. G.G. Glenner, and C.W. Wong Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein Biochem. Biophys. Res. Commun. 122 1984 1131 1135
7. I. Grundke-Iqbal Microtubule-associated protein tau. A component of Alzheimer paired helical filaments J. Biol. Chem. 261 1986 6084 6089
8. M. Goedert Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau Proc. Natl. Acad. Sci. U. S. A. 85 1988 4051 4055
9. L.A. Hansen Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa J. Neuropathol. Exp. Neurol. 52 1993 648 654
10. B.I. Giasson Interactions of amyloidogenic proteins Neuromolecular Med. 4 2003 49 58
11. U. Muller Behavioral and anatomical deficits in mice homozygous for a modified β-amyloid precursor protein gene Cell 79 1994 755 765
12. H. Zheng β-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity Cell 81 1995 525 531
13. W. Wasco Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid β protein precursor Proc. Natl. Acad. Sci. U. S. A. 89 1992 10758 10762
14. S. Heber Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members J. Neurosci. 20 2000 7951 7963
15. D. Scheuner Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease Nat. Med. 2 1996 864 870
16. V717F transgenic mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 96 1999 15233 15238
17. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
18. I. Grundke-Iqbal Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology Proc. Natl. Acad. Sci. U. S. A. 83 1986 4913 4917
19. M. Goedert Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms Neuron 8 1992 159 168
20. J. Biernat Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding Neuron 11 1993 153 163
21. G.T. Bramblett Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding Neuron 10 1993 1089 1099
22. M. Goedert Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease Neuron 3 1989 519 526
23. J. Gotz Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform EMBO J. 14 1995 1304 1313
24. C. Janke Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders Brain Res. Mol. Brain Res. 68 1999 119 128
25. A. Delacourte Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation Ann. Neurol. 43 1998 193 204
26. N. Sergeant Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively 'exon 10' isoforms J. Neurochem. 72 1999 1243 1249
27. V.M. Lee Neurodegenerative tauopathies Annu. Rev. Neurosci. 24 2001 1121 1159
28. M. Hutton Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 Nature 393 1998 702 705
29. P. Poorkaj Tau is a candidate gene for chromosome 17 frontotemporal dementia Ann. Neurol. 43 1998 815 825
30. M.G. Spillantini Mutation in the tau gene in familial multiple system tauopathy with presenile dementia Proc. Natl. Acad. Sci. U. S. A. 95 1998 7737 7741
31. S. Oddo Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction Neuron 39 2003 409 421
32. S. Oddo Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease Neurobiol. Aging 24 2003 1063 1070
33. D.R. Borchelt Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins Neuron 19 1997 939 945
34. D. Games Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein Nature 373 1995 523 527
35. L. Holcomb Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes Nat. Med. 4 1998 97 100
36. K. Hsiao Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
37. J. Lewis Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein Nat. Genet. 25 2000 402 405
38. B. Allen Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein J. Neurosci. 22 2002 9340 9351
39. M. Higuchi Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration Neuron 35 2002 433 446
40. Y. Tatebayashi Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau Proc. Natl. Acad. Sci. U. S. A. 99 2002 13896 13901
41. J. Lewis Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP Science 293 2001 1487 1491
42. J. Gotz Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Aβ 42 fibrils Science 293 2001 1491 1495
43. S. Oddo Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome Neuron 43 2004 321 332
44. Billings, L.M. et al. Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron (in press)
45. A.Y. Hsia Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models Proc. Natl. Acad. Sci. U. S. A. 96 1999 3228 3233
46. B.P. Tseng Amyloid β-peptide: the inside story Current Alzheimer Research 1 2004 231 239
47. L. Bondolfi Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice J. Neurosci. 22 2002 515 522
48. M.E. Calhoun Neuron loss in APP transgenic mice Nature 395 1998 755 756
49. K.S. Chen Neurodegenerative Alzheimer-like pathology in PDAPP 717V→F transgenic mice Prog. Brain Res. 117 1998 327 334
50. M.C. Irizarry APPSw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1 J. Neuropathol. Exp. Neurol. 56 1997 965 973
51. M.C. Irizarry Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse J. Neurosci. 17 1997 7053 7059
52. T.D. Stein, and J.A. Johnson Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways J. Neurosci. 22 2002 7380 7388
53. F.M. LaFerla The Alzheimer's Aβ peptide induces neurodegeneration and apoptosis in transgenic mice Nat. Genet. 9 1995 21 30
54. C. Andorfer Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms J. Neurochem. 86 2003 582 590
55. E. Hellstrom-Lindahl Nicotine reduces Aβ in the brain and cerebral vessels of APPsw mice Eur. J. Neurosci. 19 2004 2703 2710
56. E. Hellstrom-Lindahl Reduced levels of Aβ 40 and Aβ 42 in brains of smoking controls and Alzheimer's patients Neurobiol. Dis. 15 2004 351 360
57. A. Nordberg Chronic nicotine treatment reduces β-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw) J. Neurochem. 81 2002 655 658
58. S. Oddo Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 102 2005 3046 3051